Predictors of efficacy, mucosal healing and need for dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary

Kiss, L. S. and Czeglédi, Z. and Miheller, P. and Molnár, T. and Lakatos, László and Vincze, Á. and Palatka, K. and Gasztonyi, Beáta and Salamon, Á. and Bartha, Z. and Horváth, G. and Tóth, G. T. and Farkas, K. and Szamosi, T. and Tulassay, Z. and Papp, M. and Altorjay, I. and Nagy, F. and Banai, J. and Lakatos, P. L. (2011) Predictors of efficacy, mucosal healing and need for dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary. Journal of Crohn's and Colitis, 5 (S1). 573-P147. ISSN 1873-9946

Text JCrohnsColitis_2011.5.1_S73.pdf Restricted to Registered users only Download (545kB) | Request a copy

Actions (login required)

Edit Item